Fujifilm’s PACS gets go-ahead from Defense Department

The U.S. Department of Defense has given Fujifilm’s Synapse PACS the green light to operate on the department’s networks, granting the company an Authority to Operate (ATO) and making it the first medical-imaging vendor to obtain such clearance since DoD switched to its Risk Management Framework (RMF), according to a press release sent by Fujifilm Medical Systems USA.

DoD first announced it would be transitioning from its traditional DIACAP process for such authorization (the acronym stands for DoD Information Assurance Certification and Accreditation Process) in 2014.

The department has spent the past year implementing the change, and the new process entails myriad details and generally takes over a year to complete, Fujifilm notes.

“The Risk Management Framework provides a process that integrates security and risk management activities into the system development life cycle,” the company states, adding that the risk-based approach to security control selection and specification considers numerous factors, including constraints due to applicable laws, directives, executive orders, policies, standards and regulations.

Fujifilm COO Johann Fernando, PhD, says this particular ATO is “an unprecedented achievement in that our technology had to stand up to the rigors of a brand new risk management framework process recently implemented by the Department of Defense.”

“We look forward to our continued strong relationship with the DoD,” adds Bill Lacy, the company’s VP of medical informatics.

The new ATO granted to Fujifilm is effective until March 2020.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.